Best Selling Products
Breakthrough Therapy Designation: Paving the Way for Innovation$499.00
With the passage of the FDA Safety and Innovation Act of 2012 (FDASIA), the Breakthrough Therapy Designation (BTD) was introduced as the newest mechanism to facilitate expedited development and review. Here we provide an overview of the BTD pathway and its evolution over the past three years.April 23, 2015
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management$4,750.00
More than 40% of people in the U.S. say they have experienced recent pain, with 8% suffering from chronic pain. Direct healthcare costs associated with the treatment of pain total nearly $300 billion annually.April 4, 2016
Why Pharma Intelligence?
We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and Medtech markets.